Ottawa, May 25, 2020 – Innovative Medicines Canada (IMC) today announced the creation of a Research Chair in pandemic preparedness. IMC’s member companies will contribute $500,000 from the IMC COVID-19 Fund… Read More
SEATTLE, May 27, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will present… Read More
WARMINSTER, Pa., May 27, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today announced that William… Read More
VANCOUVER and NEW YORK, May 20, 2020 /CNW/ – ARTMS Inc. a global leader in developing technology that transforms the production of the world’s most-used diagnostic imaging isotopes, today announced that it has raised US$19 million in… Read More
May 15th, 2020, Vancouver, Canada: Alpha-9 Theranostics Inc. today announced that it has appointed two senior independent Non-Executive Directors to its Board. Appointed are: Simon Pimstone, MD, Founder and CEO… Read More
